Wenying Jian, Ph.D.
Affiliations: | 2005 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
PharmacologyGoogle:
"Wenying Jian"Parents
Sign in to add mentor| Ian A. Blair | grad student | 2005 | Penn | |
| (Lipid peroxidation-derived endogenous DNA- and GSH-adducts as biomarkers of oxidative stress.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wojcik J, Sikorski T, Wang J, et al. (2025) 2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management; ELN Migration; Ultra-Sensitivity Mass Spectrometry ( - Recommendations on Advanced Strategies for Mass Spectrometry Assays, Chromatography, Sample Preparation and BMV/Regulated Bioanalysis - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV). Bioanalysis. 1-39 |
| Baratta M, Jian W, Hengel S, et al. (2024) 2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody - Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine). Bioanalysis. 16: 307-364 |
| Szapacs M, Jian W, Spellman D, et al. (2023) 2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( - Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine). Bioanalysis |
| Kaur S, Alley SC, Szapacs M, et al. (2022) 2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid & Rare Matrices; Regulatory Inputs ( - Recommendations on Endogenous Compounds, Small Molecules, Complex Methods, Regulated Mass Spec of Large Molecules, Small Molecule, PoC & - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine). Bioanalysis. 14: 505-580 |
| Walles M, Berna MJ, Jian W, et al. (2022) . Drug Metabolism and Disposition: the Biological Fate of Chemicals |
| Khojasteh SC, Argikar UA, Driscoll JP, et al. (2021) Novel Advances in Biotransformation and Bioactivation Research - 2020 year in review. Drug Metabolism Reviews. 1-91 |
| Neubert H, Alley SC, Lee A, et al. (2021) 2020 White Paper on Recent Issues in Bioanalysis: BMV of Hybrid Assays, Acoustic MS, HRMS, Data Integrity, Endogenous Compounds, Microsampling and Microbiome ( - Recommendations on Industry/Regulators Consensus on BMV of Biotherapeutics by LCMS, Advanced Application in Hybrid Assays, Regulatory Challenges in Mass Spec, Innovation in Small Molecules, Peptides and Oligos). Bioanalysis |
| Kang L, Weng N, Jian W. (2019) LC-MS bioanalysis of intact proteins and peptides. Biomedical Chromatography : Bmc. e4633 |
| Weng N, Jian W. (2018) Selectivity for quantitation of biomarkers using liquid chromatography and mass spectrometry. Bioanalysis |
| Kang L, Connolly TM, Weng N, et al. (2017) LC-MS/MS quantification of 7α-hydroxy-4-cholesten-3-one (C4) in rat and monkey plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1064: 49-55 |